Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03207776 · ClinicalTrials.gov registry record · NA
An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPD
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 4,832
- Enrollment target
NCT03207776 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 4,832 participants.
The verdict
NCT03207776, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,832 participants
- Enrollment target
Study Summary
Patients who are hospitalized at select Carolinas Healthcare System (CHS) sites with Chronic Obstructive Pulmonary Disorder (COPD) acute exacerbation symptoms will be treated per the CHS COPD Clinical Pathway. Patient outcomes will be followed, including but not limited to readmission. Patients on the pathway will also have access to navigator services.
Interventions
- OTHER Usual Care
- OTHER COPD Clinical Pathway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,832 participants |
| Start Date | 2017-06-12 |
| Est. Completion | 2018-08-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03207776
The ClinicalTrials.gov registry entry for NCT03207776 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4,832 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT03207776 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03207776 about?
NCT03207776 is a clinical study titled "An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPD". Patients who are hospitalized at select Carolinas Healthcare System (CHS) sites with Chronic Obstructive Pulmonary Disorder (COPD) acute exacerbation symptoms will be treated per the CHS COPD Clinical Pathway. Patient outcomes will be followed, including but not limited to readmission. Patients on t...
What is the current status of trial NCT03207776?
This trial is currently completed. It is a NA study. The enrollment target is 4,832 participants. The study started on 2017-06-12. Estimated completion is 2018-08-13.
What interventions are being tested in trial NCT03207776?
The interventions under investigation include: Usual Care (OTHER), COPD Clinical Pathway (OTHER).
Who is sponsoring clinical trial NCT03207776?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.